Table 4.

Comparison of mean late gadolinium enhancement assessed by cardiac magnetic resonance imaging among the myocardial segments with and without avL ST‐elevation

Segment number	Myocardial segment	ECG STE distribution		p value
		With aVL STE (LGE %)	Without aVL STE (LGE %)
1	Basal anterior	4.6 ± 5.7	1.7 ± 3.6	0.10
2	Basal anteroseptal	11.9 ± 12.3	5.7 ± 11	0.16
3	Basal inferoseptal	2.2 ± 5.4	0.94 ± 3.5	0.45
4	Basal inferior	0 ± 0	0.26 ± 1.1	0.39
5	Basal inferolateral	0.036 ± 0.13	0 ± 0	0.26
6	Basal anterolateral	0.60 ± 1.6	0 ± 0	0.13
7	Mid anterior	32 ± 24	18 ± 16	0.06
8	Mid anteroseptal	37 ± 23	34 ± 21	0.66
9	Mid inferoseptal	9.7 ± 9.1	12 ± 16	0.65
10	Mid inferior	0.0033 ± 0.012	2.1 ± 5.2	0.18
11	Mid inferolateral	1.5 ± 5.0	0 ± 0	0.23
12	Mid anterolateral	8.1 ± 14	1.3 ± 2.8	0.06
13	Apical anterior	40 ± 22	32 ± 18	0.27
14	Apical septal	45 ± 23	55 ± 15	0.19
15	Apical inferior	11 ± 12	28 ± 21	0.02
16	Apical lateral	13 ± 18	6.2 ± 9.0	0.17
17	Apex	43 ± 24	52 ± 19	0.26

CMR: cardiac magnetic resonance; ECG: electrocardiogram; LGE: late gadolinium enhancement; STE: ST‐elevation.